Pages

Wednesday, April 27, 2011

Lung Cancer


Lung Cancer

Lung cancer is the leading cause of cancer deaths. Because of a lack of adequate detection methods, malignancies are often diagnosed at an advanced stage. While the five-year survival rate among patients with stage I lung cancer is about 70 percent, it is only 5 percent among those with stage IV disease. Unfortunately, stage I diagnoses are rare.

In 1993, the Early Lung Cancer Action Project (ELCAP) found that, with annual screening with spiral computed tomography (CT), more than 80 percent of persons diagnosed with lung cancer had stage I disease. What investigators didn't know, however, was whether early intervention was effective enough to justify screening large numbers of asymptomatic people at risk for lung cancer. 

Late in October, 2006, researchers in New York announced a finding that could very well change the entire landscape of lung cancer diagnosis and treatment. The new research shows that annual screening using computed tomography (CT) detected lung tumors at their earliest stage in 85 percent of patients.  This news out of NewYork-Presbyterian/Weill Cornell hospital and published in The New England Journal of Medicine led to an expected flurry of media reports, calling the issue of lung cancer and detection methods to the full attention of the American public and medical community. We present a few of those media reports here for your review:

Study Sees Gain on Lung Cancer


New York Times, October 26, 2006 By GINA KOLATA
Researchers in New York report that millions of lives could be saved by detecting lung cancer early with annual CT scans and treating it immediately, when it can still be cured.
The stakes are high: while death rates for other cancers have fallen, lung cancer is the leading cause of cancer deaths in this country, killing more than 160,000 people a year.

Spirometry

SPIROMETRY

Spirometry with flow volume loops assesses the mechanical properties of the respiratory system by measuring expiratory volumes and flow rates. This test requires the patient to make a maximal inspiratory and expiratory effort. The patient in a sitting position breathes into a mouthpiece, and nose clips are placed to prevent air leak. To obtain interpretable results from spirometry, it is essential that the patient give full effort during testing. At least three tests of acceptable effort are performed to ensure reproducibility of results.

Flow volume loops provide a graphic illustration of a patient's spirometric efforts. Flow is plotted against volume to display a continuous loop from inspiration to expiration. The overall shape of the flow volume loop is important in interpreting spirometric results. The volume versus time curve is an alternative way of plotting spirometric results and is another useful illustration of patient performance.
Spirometry is a versatile test of pulmonary physiology. Reversibility of airways obstruction can be assessed with the use of bronchodilators. After spirometry is completed, the patient is given an inhaled bronchodilator and the test is repeated. The purpose of this is to assess whether a patient's pulmonary process is bronchodilator responsive by looking for improvement in the expired volumes and flow rates. In general, a > 12% increase in the FEV1 (an absolute improvement in FEV1 of at least 200 ml) or the FVC after inhaling a beta agonist is considered a significant response. However, the lack of an acute bronchodilator effect during spirometry does not exclude a response to long-term therapy.
Similarly, spirometry can be used to detect the bronchial hyperreactivity that characterizes asthma. By inhaling increasing concentrations of histamine or methacholine, patients with asthma will demonstrate symptoms and produce spirometric results consistent with airways obstruction at much lower threshold concentration than normals.
Definitions and Terms
  • FEV1 - forced expiratory volume 1 - the volume of air that is forcefully exhaled in one second.
  • FVC - forced vital capacity - the volume of air that can be maximally forcefully exhaled
  • FEV1/FVC - ratio of FEV1 to FVC, expressed as a percentage
  • FEF25 - 75 - forced expiratory flow - the average forced expiratory flow during the mid (25 - 75%) portion of the FVC
  • PEF - peak expiratory flow rate - the peak flow rate during expiration
Spirometry is typically reported in both absolute values and as a predicted percentage of normal. Normal values vary depending on gender, race, age, and height. It is therefore not possible to interpret PFT's without such information. There is no single set of standard reference values, however, and "normal" varies with the reference value used in each laboratory. It is therefore important to ensure that the reference formulas in a PFT lab are applicable to the patient population being tested.

REQUIREMENTS FOR GOOD PFT’s
Obtaining useful information from pulmonary function tests requires both adequate equipment and reproducible performance. If these requirements are not met, the results must be interpreted with caution.

The American Thoracic Society (ATS) has published guidelines for the standardization of spirometry equipment and performance. Spirometric equipment should be selected to meet ATS recommendations, and at least daily monitoring and calibration must be done to obtain consistent and accurate PFT's.
Many physicians, however, are not involved in the selection of the equipment used for testing or its maintenance. But because spirometry is such an effort dependent test, they should examine each spirogram using performance criteria as set forth by the ATS. These include criteria for acceptability and reproducibility.
http://www.mededsys.com/product_info.php?cPath=2_29&products_id=87